Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Inflammatory Indexes and Gene Scores in Prediction of Atrial Fibrillation - IERV Trial

NCT06399666 is registered in ClinicalTrials.gov with Vrinnevi Hospital as lead sponsor.

NCT NCT06399666
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06399666 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Inflammatory Indexes and Gene Scores in Prediction of Atrial Fibrillation - IERV Trial
Lead sponsor
Vrinnevi Hospital
Phase
Observational
Overall status
Recruiting
Start date
October 30, 2023
Completion date
February 28, 2026
Enrollment
182 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, genetic predisposition to disease, inflammation